# Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

> **NCT04083911** · PHASE3 · UNKNOWN · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 50 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Induction Chemotherapy

## Interventions

- **DRUG:** Decitabine, Homoharringtonine, Aclarubicin, Cytarabine and G-CSF

## Key facts

- **NCT ID:** NCT04083911
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2021-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-09-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04083911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04083911, "Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04083911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*